|Bid||4.93 x 150000|
|Ask||5.07 x 150000|
|Day's range||5.07 - 5.26|
|52-week range||5.07 - 34.13|
|Beta (5Y monthly)||2.24|
|PE ratio (TTM)||N/A|
|Earnings date||23 May 2022 - 27 May 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||59.88|
Agios Pharmaceuticals (AGIO) delivered earnings and revenue surprises of 5.95% and 57.49%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zimmer (ZBH) delivered earnings and revenue surprises of 15% and 4.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
TG Therapeutics (TGTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.